Hepion Pharmaceuticals, Inc. (HEPA) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
HEPA Revenue Growth
HEPA Revenue Analysis (2014–2025)
As of May 8, 2026, Hepion Pharmaceuticals, Inc. (HEPA) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, HEPA's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including MDGL (+256.8% YoY), and HALO (+37.6% YoY). Compare HEPA vs MDGL →
HEPA Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| HEPACurrent | $0 | - | - | - | |
 MDGL | $958M | +256.8% | - | -31.3% | |
 HALO | $1.4B | +37.6% | +39.2% | 58.4% |
HEPA Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-4,163,691 | - |
| 2024 | $0 | - | $0 | - | $-19,346,578 | - |
| 2023 | $0 | - | $0 | - | $-48,447,954 | - |
| 2022 | $0 | - | $0 | - | $-45,488,726 | - |
| 2021 | $0 | - | $0 | - | $-30,403,309 | - |
| 2020 | $0 | - | $0 | - | $-20,146,075 | - |
| 2019 | $0 | - | $-26,737 | - | $-7,770,085 | - |
| 2018 | $0 | - | $-18,787 | - | $-14,594,159 | - |
| 2017 | $0 | - | $-21,938 | - | $-21,043,240 | - |
| 2016 | $0 | - | $0 | - | $-21,023,872 | - |
See HEPA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs HEPA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare HEPA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonHEPA — Frequently Asked Questions
Quick answers to the most common questions about buying HEPA stock.
Is HEPA's revenue growth accelerating or slowing?
HEPA TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is HEPA's long-term revenue growth rate?
Hepion Pharmaceuticals, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is HEPA's revenue distributed by segment?
HEPA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.